posted on 2022-05-20, 21:03authored byYongtong Lao, Meredith A. Skiba, Stephanie W. Chun, Alison R. H. Narayan, Janet L. Smith
Installation of methyl groups can
significantly improve the binding
of small-molecule drugs to protein targets; however, site-selective
methylation often presents a significant synthetic challenge. Metal-
and S-adenosyl-methionine (SAM)-dependent methyltransferases
(MTs) in natural-product biosynthetic pathways are powerful enzymatic
tools for selective or chemically challenging C-methylation reactions.
Each of these MTs selectively catalyzes one or two methyl transfer
reactions. Crystal structures and biochemical assays of the Mn2+-dependent monomethyltransferase from the saxitoxin biosynthetic
pathway (SxtA MT) revealed the structural basis for control of methylation
extent. The SxtA monomethyltransferase was converted to a dimethyltransferase
by modification of the metal binding site, addition of an active site
base, and an amino acid substitution to provide space in the substrate
pocket for two methyl substituents. A reciprocal change converted
a related dimethyltransferase into a monomethyltransferase, supporting
our hypothesis that steric hindrance can prevent a second methylation
event. A novel understanding of MTs will accelerate the development
of MT-based catalysts and MT engineering for use in small-molecule
synthesis.